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Abstract
Purpose There is concern that some generic preference-based measures (GPMs) of health-related quality of life may be insen-
sitive to interventions that improve hearing. Establishing where sensitivity arises could contribute to the design of improved 
measures. Accordingly, we compared the sensitivity of four widely used GPMs to a clinically effective treatment—cochlear 
implantation—which restores material degrees of hearing to adults with little or no functional hearing.
Methods Participants (N = 147) received implants in any of 13 hospitals in the UK. One month before implantation and 
9 months after, they completed the HUI2, HUI3, EQ5D3L, and SF-6D questionnaires, together with the EuroQoL visual-
analogue scale as a direct measure of health, a performance test of speech reception, and a self-report measure of annoyance 
due to tinnitus.
Results Implantation was associated with a large improvement in speech reception and a small improvement in tinnitus. 
HUI2 and HUI3 were sensitive to the improvement in speech reception through their Sensation and Hearing dimensions; 
EQ5D3L was sensitive to the improvement in tinnitus through its Anxiety/Depression dimension; SF-6D was sensitive to 
neither. Participants reported no overall improvement in health. Variation in health was associated with variation in tinnitus, 
not variation in speech reception.
Conclusions None of the four GPMs was sensitive to the improvements in both speech reception and tinnitus that were 
associated with cochlear implantation. To capture fully the benefits of interventions for auditory disorders, developments of 
current GPMs would need to be sensitive to both the health-related and non-health-related aspects of auditory dysfunction.
Keywords Preference-based measures · Health-related quality of life · Cochlear implantation · EQ-5D · HUI2/3 · SF-6D
Introduction
Generic preference-based measures (GPMs) of health-
related quality of life (HRQL) play important roles in the 
allocation of resources in health care because they provide 
the utility component of cost–utility analyses. Such analyses 
inform prioritisation of treatments by third-party payers in 
many jurisdictions and are mandated in England when the 
National Institute for Health and Care Excellence (NICE) 
commissions the appraisal of a health technology [1].
There is concern that some GPMs are insensitive to inter-
ventions which improve hearing [2–5]. The issue is relevant 
because impaired hearing is prevalent. A clinically signifi-
cant loss is experienced by 10% of all adults and by 30% of 
those older than 70 years [6, 7]. Sufferers must compete for 
resources to obtain treatments to alleviate their disability. 
There would be a failure of equity if treatments were denied 
not because they were ineffective but because GPMs failed 
to attribute appropriate value to their benefits.
The development of GPMs begins with researchers iden-
tifying dimensions on which good function corresponds 
to good health. Discrete levels of function are defined on 
each dimension ranging from poor to good. A subset of the 
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possible combinations of levels is valued by a representa-
tive sample of the public. These informants use methods for 
measuring preferences [8] such that their valuations lie on a 
scale where 1 corresponds to perfect health, 0 to the state of 
being dead, and negative values to states considered worse 
than dead, if relevant. Statistical modelling is used to gener-
ate a valuation function which converts any combination of 
levels into a composite index whose value best aligns with 
the valuations of the informants. Finally, a questionnaire is 
compiled to elicit a respondent’s own level of function on 
each dimension. Then, the responses to the questionnaire 
and the valuation function are deployed to assign a value 
to the respondent’s HRQL that reflects public preferences.
We examined four widely used GPMs [9–11]. The Euro-
Qol Descriptive System [9] includes dimensions relating to 
Mobility, Self-care, Usual Activities, Pain/Discomfort, and 
Anxiety/Depression. The version of the system until recently 
preferred by NICE [12] defines three levels on each dimen-
sion (EQ-5D-3L). The Mark-2 version of the Health Utili-
ties Index (HUI2) [10, 13] includes dimensions relating to 
Sensation, Mobility, Emotion, Cognition, Self-care, and 
Pain, each with 4–6 levels. In the Mark-3 version (HUI3) 
[14], Sensation was decomposed into Seeing, Hearing, and 
(being understood when) Speaking. Self-care was re-worked 
as Dexterity. The Short-Form-6D (SF-6D) [11] includes 
dimensions relating to Physical functioning, Role limita-
tions, Social functioning, Pain, Mental health, and Vitality, 
each with 4–6 levels. The dimensions are a subset of those 
in the Medical Outcomes Study Short-form Health Survey 
(SF-36) [15], such that an SF-6D utility can be derived from 
responses to the SF-36 [11].
Given differences in wording, dimensions, and methods 
of valuation, it is not surprising that the GPMs differ in their 
sensitivity to interventions [16], including interventions 
which improve hearing [e.g. 2–4]. A systematic review of 
studies that measured HRQL in participants with impaired 
hearing using one or more of EQ-5D, HUI3, and SF-6D [5] 
reached five conclusions: HUI3 was appropriate for estimat-
ing HRQL in studies involving impaired hearing; EQ-5D-3L 
was not responsive to modest changes in hearing; few studies 
had been designed to compare GPMs; only one study had 
included SF-6D; additional ‘head-to-head’ comparisons of 
GPMs were needed to understand why differences in sen-
sitivity arose.
We made such a comparison by investigating the sensitiv-
ity of the four GPMs to cochlear implantation—a clinically 
effective intervention [17] which restores auditory sensa-
tions to people with little or no functional hearing [18, 19]. 
The primary goal of implantation is to improve the ability 
to understand speech. A secondary goal is to attenuate tin-
nitus [20, 21]—“the conscious experience of a sound that 
originates in an involuntary manner in the head of its owner, 
or may appear to do so” [22]. Up to 80% of candidates for 
implantation report some degree of tinnitus [23].
The rationale for the study was that the categorical change 
from dysfunctional hearing to viable hearing that is brought 
about by implantation would allow scope for GPMs to show 
improvement if they were sensitive to hearing. The study 
adds to those in the systematic review [5] of which only two 
were prospective evaluations of implantation where partici-
pants completed questionnaires themselves; both of those 
studies included only one GPM.
Against that background, we identified reasons why the 
four GPMs differed in their sensitivity to implantation. We 
distinguished their response to impaired speech reception 
from their response to tinnitus, and we considered the impli-
cations for the choice of GPM to use in studies of hearing.
Methods
Participants
Participants were adults who met criteria of candidacy for 
implantation in the United Kingdom (UK): they had devel-
oped a severe-to-profound sensorineural hearing loss in both 
ears after acquiring spoken language; they had at least one 
patent cochlear nerve; they could identify no more than 50% 
of the content words in pre-recorded sentences presented 
in quiet without lipreading when using hearing aids. Their 
demographic and audiological characteristics are listed in 
Table 1. They received an implant in one ear in any of 13 
hospitals in the UK between June 1997 and May 2000. They 
were tested one month before implantation and again three 
and nine months after implantation as part of a larger study 
[18, 24, 25]. Results are reported for 147 participants (78 F, 
69 M) who provided a complete set of outcome measures at 
the pre-operative and 9 month post-operative stages. Online 
Resource 1 provides evidence that these participants were 
representative of adults undergoing implantation in the UK.
Outcome measures
Five measures of HRQL and two functional measures of 
hearing were derived from four questionnaires and a per-
formance test. The questionnaires were presented on touch 
screens. The performance test was conducted in audiologi-
cal test rooms. The measures are described below where 
the name given to each derived variable is italicised, e.g. 
EQ-5D-3L.
Measures of HRQL
The EQ-5D-3L questionnaire and visual-analogue scale 
of the EuroQoL Descriptive System were presented. 
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Reported levels of the five dimensions were converted to 
a composite index (EQ-5D-3L) using the valuation func-
tion described by Dolan [26]. The visual-analogue scale 
yielded a value in the range from zero (worst imaginable 
health) to 100 (best imaginable health) (EQ-VAS). For the 
Health Utilities Index Mark 2 and 3, a single questionnaire 
allowed both indices to be calculated. The words “hearing 
aid” were replaced with “cochlear implant” in the version 
of the questionnaire presented post-operatively. Reported 
levels of the dimensions were converted to weights which 
were combined to yield composite indices for HUI2 [13] 
and HUI3 [14] (HUI2, HUI3). For the Short-Form-6D, 
responses to the UK SF-36 questionnaire [27] were ana-
lysed to determine the level of function of each participant 
on each dimension and then to compute a composite index 
[28] (SF-6D).
Functional measures of hearing
A measure of speech reception was obtained by presenting 
recordings of sentences to participants at an intensity typical 
of conversational speech and counting the percentage of con-
tent words reported correctly [18, 29] (Speech). A measure 
of annoyance due to tinnitus was obtained by presenting 13 
questions [30; Online Resource 2] which probed the subjec-
tive manifestations of tinnitus and its psychological impact. 
Participants responded by positioning a pointer on a visual-
analogue scale whose ends were labelled appropriately for 
each question. Responses were averaged and expressed as 
a number in the range from 0 (no annoyance) to 100 (great 
annoyance) (Tinnitus).
A good outcome from implantation is characterised by a 
high value of Speech and a low value of Tinnitus. Thus, to 
the extent that speech reception and annoyance due to tin-
nitus are associated with HRQL, Speech and Tinnitus are 
expected to display complementary patterns of correlation; 
where Speech correlates positively, Tinnitus should correlate 
negatively, and vice versa.
Analyses
Analyses were conducted with IBM SPSS Statistics v.24 
[31].
Sensitivity of outcome measures to implantation
We tested the sensitivity of each outcome measure to 
implantation by determining whether the change from the 
pre-operative to the post-operative value of the measure 
exceeded zero using a t test. Effect sizes (ES) were assessed 
with the Standardised Response Mean [32] and, for descrip-
tive convenience, were classified as small (0.2 ≤ ES < 0.5), 
moderate (0.5 ≤ ES < 0.8), or large (0.8 ≤ ES). The changes 
in the four composite indices were compared in an analysis 
of variance. Mauchly’s test of sphericity was significant, so 
the Greenhouse-Geisser adjustment was made to the degrees 
of freedom.
Sensitivity of individual dimensions of GPMs 
to implantation
To establish which dimensions of each GPM were sensitive 
to implantation, and to determine whether positive changes 
on some dimensions were offset by negative changes on 
others, we identified dimensions on which there was a sig-
nificant change—either positive or negative—between the 
levels to which participants assigned themselves before and 
after implantation using a Wilcoxon signed-rank test.
Table 1  Biographical and audiological characteristics of participants before implantation
a Elevation of detection thresholds for pure tones averaged across the acoustic frequencies of 500, 1000, 2000, and 4000 Hz relative to normal 
hearing
b Self-reported by participants
c BKB Sentence Test [18, 29]
Measure Minimum Maximum Mean Standard 
deviation
Age at the time of implantation (years) 18.0 79.3 50.7 14.7
Pre-operative hearing  levela of the implanted ear (dB) 88.8 140.0 118.3 10.5
Pre-operative hearing  leveal of the other ear (dB) 93.8 140.0 117.5 10.5
Duration of severe-profound  deafnessb of the implanted ear (years) 0.0 71.0 14.8 15.7
Duration of severe-profound  deafnessb of the other ear (years) 0.0 71.0 14.9 15.4
Pre-operative speech-reception score (% correct)c 0.0 50.0 3.8 9.3
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Sensitivity of composite indices to speech reception 
and tinnitus
A composite index could be sensitive to variation in both 
speech reception and tinnitus, to one, or to neither. To deter-
mine which pattern of sensitivity was shown by each GPM, 
we calculated Kendall rank correlation coefficients between 
changes in Speech and Tinnitus and changes in each com-
posite index. We also examined whether values of Speech 
and Tinnitus before and, separately, after implantation were 
correlated with the pre- and post-operative values of the 
composite indices.
Sensitivity of individual dimensions to speech reception 
and tinnitus
To determine which individual dimensions underpinned 
correlations between composite indices and Speech and 
Tinnitus, we calculated Kendall rank correlation coef-
ficients between changes in the levels of each dimension 
and changes in Speech and Tinnitus. We also tested whether 
values of Speech and Tinnitus before and after implantation 
were correlated with the pre- and post-operative levels of 
individual dimensions.
Results
Sensitivity of outcome measures to implantation
Table 2 reports the sensitivity of the outcome measures to 
implantation. In terms of effect size, HUI2 displayed a mod-
erate significant change and HUI3 a large significant change. 
EQ-5D-3L displayed a small significant change. SF-6D 
and EQ-VAS did not show significant changes. Analysis of 
variance showed that the four changes differed significantly 
 (F(2.4,345.2) = 45.3, p < 0.001); all pair-wise comparisons were 
significant (p < 0.001), except the comparison between EQ-
5D-3L and SF-6D.
The first functional measure of hearing, Speech, increased 
from 3.8% correct to 56.1% correct with a large effect size. 
The second functional measure, Tinnitus, declined from 
23.9 to 16.8 with a small effect size. Thus, implantation was 
associated with a large primary effect of improved speech 
reception and a small secondary effect of reduced annoyance 
due to tinnitus. Online Resource 3 provides additional sup-
port for the interpretation of speech reception as the primary 
outcome and annoyance due to tinnitus as the secondary 
outcome.
Sensitivity of individual dimensions of GPMs 
to cochlear implantation
Table 3 summarises the sensitivity of the individual dimen-
sions of the GPMs to implantation. For each dimension, the 
table includes the number of participants who placed them-
selves at each level before and after implantation, together 
with the results of a comparison of the 147 pairs of levels. As 
an example, consider the entry for the Anxiety/Depression 
dimension of EQ-5D-3L which is at top-right in the table. 
Before implantation, 83 participants placed themselves at the 
best level of this dimension, 52 at the middle level, and 12 at 
the worst level, summarised as (83,52,12). After implanta-
tion, the pattern had improved significantly to (113,30,4) 
(Wilcoxon z = 4.812, p < 0.001).
Implantation was associated with three types of change: 
improvements in Sensation (HUI2), Hearing (HUI3), and 
Speaking (HUI3); improvements in Anxiety/Depression (EQ-
5D-3L) and Mental Health (SF-6D); and a worsening of 
Pain (HUI2, SF-6D). Thus, each GPM included at least one 
dimension that displayed a significant improvement, while 
HUI2 and SF-6D also included dimensions that worsened 
significantly.
Table 2  Comparison of values 
of outcome measures before and 
after implantation
a Calculated as the post-operative value minus the pre-operative value. Improvements are shown by a nega-
tive change in Tinnitus (i.e. a reduction in annoyance) and by a positive change in other outcome measures
b *p < 0.05, ***p < 0.001
c Adjusted standardised response mean [32]
Outcome measure
EQ-5D-3L HUI2 HUI3 SF-6D EQ-VAS Speech Tinnitus
Mean pre-operative value 0.788 0.640 0.433 0.763 76.66 3.81 23.94
Mean post-operative value 0.827 0.775 0.629 0.775 77.93 56.08 16.81
Mean change in  valuea 0.040 0.135 0.197 0.012 1.26 52.27 − 7.13
Student’s t146b 2.30* 8.16*** 12.10*** 1.20 1.00 18.36*** − 4.05***
Adjusted  SRMc 0.20 0.71 1.06 0.12 0.09 1.18 − 0.35
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Table 3  Comparison of numbers of participants at each level of each dimension of GPMs before and after implantation
a N Pre Number of participants at each level of a dimension before implantation. Left-hand number in parentheses is the number at the most 
advantageous level of the dimension; right-hand number is the number at the least advantageous level
b N Post Number of participants at each level of a dimension after implantation
c Z statistic from Wilcoxon signed-rank comparison of pre- and post-operative levels. A negative value indicates that the mean level became less 
advantageous. A positive value indicates that the mean level became more advantageous
d *p < 0.05, **p < 0.01, ***p < 0.001
EQ-5D-3L dimensions
Mobility Self-care Usual activities Pain/discomfort Anxiety/depression
N  Prea (110,37,0) (140,7,0) (113,28,6) (99,42,6) (83,52,12)
N  Postb (108,39,0) (139,8,0) (118,27,2) (89,52,6) (113,30,4)
Zc,d − 0.47 − 0.33 + 1.50 − 1.54 + 4.81***
HUI2 dimensions
Sensation Mobility Emotion Cognition Self-care Pain
N Pre (0,9,65,73) (125,8,13,1,0) (95,42,8,2,0) (103,42,2,0) (146,1,0,0) (116,10,9,4,8)
N Post (0,80,62,5) (127,6,12,2,0) (105,37,4,1,0) (110,34,3,0) (143,2,0,2) (93,30,7,0,17)
Z + 8.92*** 0.000 + 1.79 + 0.93 − 1.52 − 2.85**
HUI3 dimensions
Vision Hearing Speaking Ambulation Dexterity Emotion Cognition Pain
N Pre (48,96,1,1,1,0) (3,1,11,4,56,72) (106,21,13,5,2) (125,8,13,0,1,0) (145,0,0,2,0,0) (97,37,7,5,1) (103,12,16,13,3,0) (85,27,24,8,3)
N Post (41,104,0,1,1,0) (0,2,107,0,33,5) (114,22,11,0,0) (127,6,12,1,0,1) (147,0,0,0,0,0) (94,41,12,0,0) (110,7,14,12,4,0) (72,37,27,10,1)
Z − 1.26 + 9.22*** + 2.08* + 0.17 + 1.41 + 0.30 + 0.64 − 1.28
SF-6D dimensions
Physical Role limitations Social Pain Mental health Vitality
N Pre (56,46,19,7,15,4) (95,19,16,17) (96,16,22,9,4) (73,22,29,9,11,3) (27,46,45,26,3) (13,75,40,13,6)
N Post (51,43,29,7,13,4) (96,10,14,27) (93,21,24,6,3) (60,30,21,22,12,2) (51,42,40,12,2) (17,70,45,11,4)
Z − 0.80 − 1.11 + 0.24 − 2.13* + 4.53*** + 0.86
Table 4  Kendall rank-order 
coefficients of correlation 
among functional measures of 
hearing and measures of HRQL
Low values of Tinnitus, but high values of Speech and of measures of HRQL, were advantageous pre- and 
post-operatively. A negative change in Tinnitus, but a positive change in Speech and in measures of HRQL, 
represented improvements. Thus, correlations between Tinnitus and measures of HRQL were negative, 
while correlations between Speech and measures of HRQL were positive
Significance assessed against Bonferroni-adjusted alpha levels of 0.01 per test (0.05/5) (*) and 0.002 per 
test (0.01/5) (**)
a Correlations among changes in measures; change was calculated as the post-operative value minus the 
pre-operative value
b Correlations among pre-operative values of measures
c Correlations among post-operative values of measures
Tinnitus EQ-5D-3L HUI2 HUI3 SF-6D EQ-VAS
Change in  valuesa
 Speech − 0.056 0.118 0.185** 0.191** 0.051 − 0.004
 Tinnitus − 0.182* − 0.112 − 0.069 − 0.054 − 0.179**
Pre-operative  valuesb
 Speech − 0.053 0.022 0.178 * 0.137 0.135 0.053
 Tinnitus − 0.223** − 0.230** − 0.242** − 0.247** − 0.225**
Post-operative  valuesc
 Speech 0.002 0.128 0.195** 0.189** 0.136 0.044
 Tinnitus − 0.242** − 0.201** − 0.206** − 0.251** − 0.236**
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Sensitivity of measures of HRQL to speech reception 
and tinnitus
The upper panel of Table 4 lists Kendall rank-order cor-
relation coefficients between change in Speech and Tinnitus 
and change in each measure of HRQL. Change in Speech 
was correlated with change in HUI2 and HUI3, but not 
with change in EQ-5D-3L or EQ-VAS. Change in Tinnitus 
showed the opposite pattern; it was correlated with change 
in EQ-5D-3L and EQ-VAS, but not with change in HUI2 or 
HUI3. Change in neither functional measure was correlated 
with change in SF-6D. Thus, none of the composite indices 
was sensitive to the improvements in both speech reception 
and tinnitus associated with implantation. Online Resource 
4 includes multiple regression analyses which corroborate 
these patterns of correlation.
The middle and lower panels of Table 4 list coefficients 
of correlation between the functional measures of hearing 
and the measures of HRQL before and after implantation. 
Of the five measures of HRQL, only HUI2 was correlated 
with Speech before implantation, and only HUI2 and HUI3 
were correlated with Speech after implantation. In contrast, 
each measure of HRQL was correlated with Tinnitus, both 
before and after implantation.
Sensitivity of individual dimensions to speech 
reception and tinnitus
Table 5 lists coefficients of correlation between the levels of 
individual dimensions and measures of Speech and Tinnitus. 
The results corroborate the implication of Table 4 that the 
GPMs were more attuned to variation among participants in 
Tinnitus than in Speech. The four GPMS together contain 25 
dimensions. Variation in Speech was correlated significantly 
with the levels of only four of them before or after implan-
tation, while variation in Tinnitus was correlated with 15.
Discussion
The data reported here were gathered in the late 1990s. 
Improvements in cochlear implants and changes in candi-
dature might have rendered the results irrelevant to today’s 
outcomes. Two considerations counter those concerns. First, 
criteria of candidacy for unilateral implantation of adults in 
England [17] remain the same as the entry criteria for the 
study, although they are currently under review [33]. Sec-
ond, accuracy of speech reception following implantation 
has plateaued since the mid-1990s [34]. Thus, participants in 
the study, and patients receiving implants in England today, 
are likely to come from the same population and to dem-
onstrate the same patterns of association among outcome 
measures.
With those caveats, the study provides evidence at three 
levels of detail to inform the choice of GPM to use in assess-
ments of interventions for hearing disorders. First, at the 
level of composite indices, the results corroborate previous 
demonstrations [2–5] that GPMs differ in their sensitivity 
to treatments which improve hearing (Table 2): HUI2 and 
HUI3 showed moderate or large responses to implantation; 
EQ-5D-3L showed a small response; and SF-6D showed 
no response. In consequence, economic analyses informed 
by HUI2 or HUI3 suggest that implantation is a cost-effec-
tive intervention, while analyses informed by EQ-5D-3L 
or SF-6D suggest that it is not (Online Resource 5). That 
result might argue that only HUI3 need be used in studies 
of hearing.
However, limitations in all of the GPMs emerge at the 
second level of detail where the changes associated with 
implantation on individual dimensions are considered 
(Table 3). Significant changes occurred on three groups of 
dimensions: positive changes resulting from improved audi-
tory sensitivity; positive changes resulting from improved 
psychological well-being; and negative changes presum-
ably resulting from pain caused by the surgical wound and 
from irritation induced by wearing the external parts of the 
implant system against the scalp. Limitations of the GPMs 
are shown by the fact that no GPM displayed all three types 
of change.
It is not surprising that the composite indices of HUI2 and 
HUI3 were sensitive to the improvement in speech reception, 
given that the questions which map respondents onto the lev-
els of the Sensation (HUI2) and Hearing (HUI3) dimensions 
ask about the ability to “hear what is said” in conversation. 
More surprising may be that neither Usual Activities (EQ-
5D-3L) nor Role Limitations or Social Functioning (SF-6D) 
were similarly sensitive. However, participants had been 
severely profoundly hearing impaired for nearly 15 years 
on average (Table 1), so their “usual” activities would have 
adapted to constraints imposed by their deafness. Also, the 
questions that map respondents onto levels of the Role Limi-
tations and Social Functioning dimensions emphasise limi-
tations arising from health. The loss of hearing sensitivity 
that underpins impaired speech reception is not usually the 
consequence of disease [35] nor is it generally perceived to 
be a manifestation of ill-health [36].
In contrast, evidence from the third level of detail—indi-
vidual differences in outcome measures before and after 
implantation—shows that annoyance due to tinnitus was 
perceived to be strongly related to perceptions of health 
(Table 4b). It was associated with poorer levels of func-
tion on dimensions related to physical activity (Mobility 
and Usual Activities in EQ-5D-3L, Role Limitations and 
Social Function in SF-6D), pain (Pain/Discomfort in EQ-
5D-3L, Pain in HUI2, HUI3, SF-6D), and mental health 
(Anxiety/Depression in EQ-5D-3L, Emotion in HUI3, 
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Table 5  Kendall rank-order 
coefficients of  correlationa 
between functional measures of 
hearing and levels of individual 
dimensions of GPMs
GPM Dimension Pre-operative Post-operative Change
τb Sig.e τc Sig.e τd Sig.e
(a) Correlations with Speech
 EQ-5D-3L Mobility − 0.090 − 0.041 0.020
Self-care 0.030 − 0.097 − 0.015
Usual activities 0.036 − 0.019 − 0.060
Pain/Discomfort − 0.021 − 0.064 − 0.003
Anxiety/Depression 0.020 − 0.212 * − 0.174 *
 HUI2 Sensation − 0.359 ** − 0.263 ** − 0.230 **
Mobility − 0.112 − 0.083 − 0.096
Emotion − 0.008 − 0.068 − 0.082
Cognition 0.094 − 0.154 − 0.054
Self-care − 0.047 − 0.027 − 0.057
Pain 0.052 − 0.075 − 0.040
 HUI3 Vision 0.055 − 0.071 − 0.058
Hearing − 0.325 ** − 0.193 * − 0.225 **
Speaking 0.074 − 0.165 0.023
Ambulation − 0.112 − 0.083 − 0.096
Dexterity − 0.066 f − 0.071
Emotion − 0.022 − 0.061 − 0.071
Cognition 0.092 − 0.159 − 0.085
Pain − 0.060 − 0.102 0.006
 SF-6D Physical functioning − 0.098 − 0.112 − 0.097
Role limitations − 0.092 − 0.078 − 0.019
Social functioning − 0.131 − 0.115 − 0.134
Pain − 0.051 − 0.090 − 0.047
Mental Health − 0.163 − 0.201 ** − 0.055
Vitality − 0.035 − 0.025 − 0.031
(b) Correlations with Tinnitus
 EQ-5D-3L Mobility 0.216 * 0.227 ** 0.062
Self-care 0.072 − 0.017 − 0.031
Usual activities 0.204 * 0.250 ** 0.150
Pain/discomfort 0.180 * 0.208 * 0.134
Anxiety/depression 0.136 0.194 * 0.185 *
 HUI2 Sensation 0.207 * 0.054 0.042
Mobility 0.173 0.123 − 0.103
Emotion 0.076 0.125 0.053
Cognition 0.174 0.171 0.120
Self-care 0.007 − 0.033 − 0.126
Pain 0.137 0.201 * − 0.004
 HUI3 Vision − 0.095 0.073 − 0.029
Hearing 0.193 * 0.083 0.043
Speaking 0.041 0.003 − 0.032
Ambulation 0.173 0.123 − 0.103
Dexterity 0.068 f − 0.075
Emotion 0.199 * 0.197 * 0.034
Cognition 0.181 * 0.167 0.124
Pain 0.162 0.189 * 0.050
 SF-6D Physical functioning 0.164 0.149 − 0.012
Role limitations 0.172 * 0.255 ** 0.133
Social functioning 0.245 ** 0.178 * 0.142
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Mental Health in SF-6D). This pattern (see also [37]) can 
be rationalised by the ideas that the negative influence of 
tinnitus on the capacity to concentrate reduces productive 
activity [38], that tinnitus is discomforting and akin to pain 
[39, 40], and that tinnitus either elevates anxiety [41] or 
anxiety exacerbates the experience of tinnitus [42].
The conclusion that the GPMs are more attuned to tinni-
tus than impaired speech reception is reinforced by the find-
ing that variation among participants in the change in self-
reported health, EQ-VAS, was correlated with the change in 
Tinnitus, not the change in Speech (Table 4). The conclusion 
is supported by supplementary analyses in Online Resource 
6 and is also compatible with analyses reported by Konerd-
ing et al. [16] who examined patterns of association among 
dimensions of EQ-5D-3L, HUI2, and SF-6D. Correlated pat-
terns across the three GPMs were found among dimensions 
related to mental health and, separately, physical function-
ing, and physical pain. The Sensation dimension of HUI2, 
however, was not related to other dimensions, suggesting 
that sensory deficits are independent of other aspects of 
health. That conclusion anticipates the demonstration in the 
present paper and elsewhere [2–5] that sensitivity to inter-
ventions which improve the ability to detect sounds is shown 
only by those GPMs that explicitly measure the benefits of 
improved auditory sensitivity.
Which GPM should be used in studies of hearing? Con-
sider first that Tinnitus was associated with aspects of health 
which are represented by dimensions in each GPM. All of 
the GPMs, therefore, have the potential to be sensitive to 
changes in health produced by interventions which reduce 
annoyance due to tinnitus. Although in the present study 
only EQ-5D-3L was sensitive to the small improvement 
in Tinnitus (Table 4), in a clinical trial reported by Maes 
et al. [43], both EQ-5D-3L and HUI3 distinguished patients 
whose tinnitus improved from patients whose tinnitus did 
not improve, with HUI3 showing slightly greater sensitivity. 
Thus, in jurisdictions where policy makers prefer HUI3, it 
should be used in studies of hearing, insofar as it has been 
shown to be sensitive to improvements in both tinnitus and 
auditory sensitivity.
In jurisdictions where policy makers prefer EQ-5D, it 
should be used to evaluate interventions intended to improve 
tinnitus, while HUI3 should be used to evaluate interven-
tions intended to improve hearing sensitivity. That distinc-
tion aligns with the guidance given by NICE that alternatives 
to EQ-5D should be used to evaluate conditions for which 
EQ-5D lacks critical dimensions of health [1]. Nonetheless, 
it is unsatisfactory to advocate the use of different GPMs to 
assess treatments for two aspects of dysfunctional hearing 
which can co-occur and which can both respond to the same 
treatment. The dilemma reinforces the aim of a consortium 
of researchers in the UK [44] to develop a successor to the 
EuroQol Descriptive System which preserves sensitivity to 
the conventional dimensions of health while adding sensitiv-
ity to sensory disorders [45, 46] among other changes.
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